Spire Wealth Management’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-15
Closed -$925 2368
2025
Q4
$925 Buy
+15
New +$918 ﹤0.01% 2205
2023
Q2
Sell
-21
Closed -$1.31K 2496
2023
Q1
$1.31K Sell
21
-107
-84% -$6.68K ﹤0.01% 2351
2022
Q4
$8K Buy
+128
New +$7.34K ﹤0.01% 1704
2022
Q3
Sell
-15
Closed -$1K 2486
2022
Q2
$1K Buy
+15
New +$827 ﹤0.01% 2559

Other funds holding PBH

Spire Wealth Management's PBH Position: Q1 2026 in Review

Spire Wealth Management sold out of Prestige Consumer Healthcare (PBH) in Q1 2026, closing a stake of 15 shares — an estimated $925 sold.

Spire Wealth Management first reported a position in PBH in Q2 2022 and held it in 4 quarters. The position peaked at $8K in Q4 2022. 355 funds tracked by Wall St. Rank hold PBH as of Q1 2026.

  • Spire Wealth Management reported no remaining Prestige Consumer Healthcare position as of Q1 2026 after selling out during the quarter.
  • Spire Wealth Management sold 15 Prestige Consumer Healthcare shares in Q1 2026, an estimated $925.
  • Spire Wealth Management first reported a position in Prestige Consumer Healthcare in Q2 2022 and held it in 4 quarters.
  • Spire Wealth Management's Prestige Consumer Healthcare position peaked at $8K in Q4 2022.
  • 355 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2026.

Based on Spire Wealth Management's 13F filing for Q1 2026, filed 22 Apr 2026.